Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052459

Director acquired 5,295,307 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2020-09-28 Conversion +3,275,205 3,275,205 I
Manning Paul B Director 2020-09-28 Conversion +2,008,158 2,008,158 I
Manning Paul B Director 2020-09-28 Conversion +11,944 2,020,102 I
Derivatives
Manning Paul B Director 2020-09-28 Conversion · Series A Preferred Stock −3,006,155 0 I
Manning Paul B Director 2020-09-28 Conversion · Series A Preferred Stock −1,843,193 0 I
Manning Paul B Director 2020-09-28 Conversion · Series B Preferred Stock −10,963 0 I
Loading xslF345X03/doc4.xml…